Details

MIPS - Quality Measures - Hematology: Multiple Myeloma: Treatment with Bisphosphonates

Quality Measures
Category QUALITY
Description Percentage of patients aged 18 years and older with a diagnosis of multiple myeloma, not in remission, who were prescribed or received intravenous bisphosphonate therapy within the 12 month reporting period
eMeasure ID
First Performance Year 2017
Last Performance Year
Metric Type Single Performance Rate
National Quality Strategy Domain ECC
Measure Type Process
eMeasure UUID
NQF eMeasure ID
NQF ID 0380
Is High Priority?
Is Inverse?
Overall Algorithm
Primary Steward American Society of Hematology
Submission Methods Registry
Eligibility Options
Performance Options
Is Risk Adjusted?
Vendor ID
Is Registry Measure?
Registry Measure Spec https://qpp.cms.gov/docs/QPP_quality_measure_specifications/Claims-Registry-Measures/2017_Measure_069_Registry.pdf
Web Interface Measure Spec
Claims Measure Spec

Back to List